As of Sep 22
| -0.33 / -0.58%|
The 3 analysts offering 12-month price forecasts for Anika Therapeutics Inc have a median target of 53.00, with a high estimate of 60.00 and a low estimate of 45.00. The median estimate represents a -6.51% decrease from the last price of 56.69.
The current consensus among 3 polled investment analysts is to Buy stock in Anika Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.